Shape-memory alloy loop snare for endoscopic photodynamic therapy of early gastric cancer

Endoscopy

Volumn 32, Issue 8, 2000, Pages 609-613

  Nakamura, T ^a   Fukui, H ^b   Ishii, Y ^c   Fujita, M ^d   Hori, K ^e   Ejiri, K ^c   Ejiri, M ^c   Fujimori, T ^d  

^a Kobe National Hospital   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Jyoyo Ejiri Hospital   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e Hori GIS Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN II; PHOTOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; ENDOSCOPIC THERAPY; EXCIMER LASER; FEMALE; HUMAN; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; STOMACH CANCER;

AGED; AGED, 80 AND OVER; EQUIPMENT DESIGN; FEMALE; GASTRIC MUCOSA; GASTROSCOPY; HEMATOPORPHYRIN PHOTORADIATION; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 0033909662     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9013     Document Type: Article

References (13)

1. Gregorie HB, Horger EO, Ward JL, et al. Hematoporphyrin-derivative fluorescence in malignant neoplasms. Ann Surg 1968; 167: 820-828
2. Weishaup KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976; 36: 2326-2329
3. 14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 1979; 39: 146-151
4. Ell C, Grossner L, May A, et al. Photodynamic therapy of early gastric cancer with mTHPC. Gut 1998; 43: 345-349
5. Grossner L, Sroka, R, Hahn EG, Ell C. Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid. Gastrointest Endosc 1995; 41: 55-58
6. Fujimori T, Nakamura T, Yoshida S, et al. Endoscopic mucosectomy for early gastric cancer using modified strip biopsy. Endoscopy 1992; 24: 187-189
7. Mimura S, Ito Y, Hayata Y, et al. Cooperative clinical trial of photodynamic therapy with Photofrin II and excimer dye laser for early gastric cancer. Lasers Surg Med 1996; 19: 168-172
8. Dellinger M, Vever-Bizet C, Brault D, et al. Uptake and photodynamic efficiency of hematoporphyrin, hydroxyethylvinyldeuteroporphyrin and hematoporphyrin derivative (Photofrin II): a study with isolated mitochondria. Photochem Photobiol 1990; 51: 185-189
9. Tsuchida T, Zheng G, Pandey RK, et al. Correlation between site II-specific human serum albumin (HSA) binding affinity and murine in vivo photosensitizing efficacy of some Photofrin components. Photochem Photobiol 1997; 66: 224-228
10. Schomacker KT, Walsh A, Gregory KW, Kochevar IE. Cell damage induced by Angiovist-370 and 308 nm excimer laser radiation. Lasers Surg Med 1997; 20: 111-118
11. Kochevar IE, Walsh AA, Green HA, et al. DNA damage induced by 193-nm radiation in mammalian cells. Cancer Res 1991; 51: 288-293
12. Mimura S, Ichii M, Imanishi K, et al. Evaluation of photodynamic therapy for gastric cancer. Dig Endosc 1990; 2: 265-274
13. Sibille A, Descamps C, Jonard P, et al. Endoscopic Nd:YAG treatment of superficial gastric carcinoma: experience in 18 Western inoperable patients. Gastrointest Endosc 1995; 42: 340-345